Comparison of causes of drug discontinuation between anti-TNF agents and 'non-anti-TNF biologic agents' in anti-TNF inadequate responder RA patients

被引：0
|
作者：
Du Pan, S. Martin [1 ]
Neto, D. [1 ]
Zufferey, P. [2 ]
Ciurea, A. [3 ]
Ziswiler, H. R. [4 ]
Gabay, C. [1 ]
Finckh, A. [1 ]
机构：
[1] HUG, Rheumatol, Geneva, Switzerland
[2] CHU Vaudois, Rheumatol, Lausanne, Switzerland
[3] USZ, Rheumatol, Zurich, Switzerland
[4] Inselspital Bern, Rheumatol, Bern, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2013年 / 143卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 10
引用
收藏
页码：5S / 5S
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF DRUG DISCONTINUATION TO INEFFICACY AND ADVERSE EVENTS BETWEEN ANTI-TNF AGENTS AND 'NON-ANTI-TNF BIOLOGIC AGENTS' IN ANTI-TNF INADEQUATE RESPONDER RHEUMATOID ARTHRITIS PATIENTS
    Martin-du-Pan, S.
    Neto, D.
    Zufferey, P.
    Ciurea, A.
    Ziswiler, H.
    Gabay, C.
    Finckh, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 615 - 615
  • [2] Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF
    Wilke, T.
    Mueller, S.
    Majer, I.
    Heisen, M.
    Fuchs, A.
    Maywald, U.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] ANTI-TNFα ANTIBODY VERSUS NON-ANTI-TNFα MOLECULAR AGENTS FOR ULCERATIVE COLITIS PATIENTS WHO FAILED INITIAL ANTI-TNFα THERAPY
    Kanayama, Kengo
    Kato, Jun
    Shiratori, Wataru
    Nagashima, Ariki
    Ohta, Yuki
    Taida, Takashi
    Saito, Keiko
    Goto, Chihiro
    Kurosugi, Akane
    Ishikawa, Tsubasa
    Kaneko, Tatsuya
    Akizue, Naoki
    Okimoto, Kenichiro
    Matsumura, Tomoaki
    Kato, Naoya
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1098 - S1098
  • [4] Anti-TNFα antibody versus non-anti-TNFα molecular agents for ulcerative colitis patients who failed initial anti-TNFα therapy
    Kanayama, Kengo
    Kato, Jun
    Shiratori, Wataru
    Nagashima, Ariki
    Ohta, Yuki
    Taida, Takashi
    Saito, Keiko
    Goto, Chihiro
    Takahashi, Satsuki
    Horio, Ryosuke
    Kurosugi, Akane
    Ishikawa, Tsubasa
    Kaneko, Tatsuya
    Akizue, Naoki
    Okimoto, Kenichiro
    Matsumura, Tomoaki
    Kato, Naoya
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (06) : 1083 - 1089
  • [5] Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients
    Du Pan, Sophie Martin
    Scherer, Almut
    Gabay, Cem
    Finckh, Axel
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 997 - 999
  • [6] Comparison of drug retention rates and causes of drug discontinuation between anti-TNF agents in rheumatoid arthritis patients
    Du Pan, S. M. C. Martin
    Dehler, S.
    Gabay, C.
    Finckh, A.
    [J]. SWISS MEDICAL WEEKLY, 2007, 137 : 3S - 3S
  • [7] Comparison of drug retention rates and causes of drug discontinuation between anti-TNF agents in rheumatoid arthritis patients
    Du Pan, S. M. C. Martin
    Dehler, S.
    Gabay, C.
    Finckh, A.
    Scqm-Ra, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 181 - 181
  • [8] Predictors of response to anti-TNF agents in patients with RA
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 (3): : 127 - 127
  • [9] Infection risk in RA patients on anti-TNF agents
    Breen, P
    Gerbino, AJ
    Barnes, R
    Hillson, JL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 298 - 299
  • [10] Drug survival time on anti-TNF agents: Does prior anti-TNF use influence RA outcomes?
    Kishimoto, M
    Greenberg, J
    Abramson, SB
    Harrington, T
    Olenginski, TP
    Kafka, SP
    Reed, G
    Hinkle, K
    Kremer, J
    Cohen, SB
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S347 - S347
12345